학술논문
Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT
Document Type
Article
Author
Geerlinks, Ashley V.; Scull, Brooks; Krupski, Christa; Fleischmann, Ryan; Pulsipher, Michael A.; Eapen, Mary; Connelly, James A.; Bollard, Catherine M.; Pai, Sung-Yun; Duncan, Christine N.; Kean, Leslie S.; Baker, K. Scott; Burroughs, Lauri M.; Andolina, Jeffrey R.; Shenoy, Shalini; Roehrs, Philip; Hanna, Rabi; Talano, Julie-An; Schultz, Kirk R.; Stenger, Elizabeth O.; Lin, Howard; Zoref-Lorenz, Adi; McClain, Kenneth L.; Jordan, Michael B.; Man, Tsz-Kwong; Allen, Carl E.; Marsh, Rebecca A.
Source
In Blood Advances 25 July 2023 7(14):3725-3734
Subject
Language
ISSN
2473-9529